Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

MCR-1 thought to be 'circulating' in the US
pig
MCR-1 was first discovered in multiple samples from pigs, pork and humans in China late last year.(stock photo)
Second pig sample found to contain colistin-resistant bacteria
 
US health officials have found bacteria that is resistant to the 'last resort' antibiotic, colistin, in a second pig sample. A similar discovery was made last month in a human patient.

Experts say there is growing evidence that the MCR-1 gene - which allows bacteria to become resistant to colistin - is circulating in the US. It is feared the gene could spread to bacteria that can only be treated with colistin, creating a superbug that is immune to all available antibiotics.

The latest discovery was made during testing at a slaughterhouse in Illinois, according to the Washington Post. E.coli bacteria carrying the gene was identified in a pig intestine, a spokeswoman for the US Department of Agriculture is reported to have said.

This is the second pig sample in the US found to contain resistant bacteria. A different strain of E.coli carrying MCR-1 was discovered in the intestines of a pig from another state last month.

For the first time, MCR-1 was also detected in a human patient in the US. E.coli bacteria carrying the gene was identified in a urine sample from the 49-year-old Pennsylvania resident.

Patrick McGann from the US Department of Defense, is quoted by the Washington Post as saying: "Mounting evidence suggests the MCR-1 gene is circulating within the United States. Our sample was in a woman with no recent travel history, the pig samples are from slaughterhouses in the USA, and [the] strains are all different."

Scientists across the globe have been looking for the gene since it was first discovered in multiple samples from pigs, pork and humans in China late last year.

Colistin is one of the last resort drugs, used to treat bacteria that is resistant to other antibiotics. The concern is that MCR-1 exists on a plasmid - a small piece of DNA - that can move from one bacterium to another, spreading antibiotic resistance. The gene has since been found in Europe and Canada, as well as the US.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.